PharmaCyte Biotech Inc (PMCB)

[Ciab]

wow Rudy, so I believe this was the case for the CiaB/Melligen Cells patent...cool

Besides in vivo use, encapsulation of antibody or antibody like producing cells can be of great interest for the industrial production of antibodies by the biotech industry. The capsules can act as a pre-filtration device and eliminate cost-intensive steps during downstream processing of antibody products. Such encapsulated products should be seen favourably by industry since they may allow for new IP surrounding old technologies in combination with capsules. This may allow generation of new patents or extension of old patents, something it can be assumed is much needed when looking at the current portfolios of many of the large pharmaceutical companies.